Amgen Inc. (BMV:AMGN)

Heartland Financial USA Statistics

Total Valuation

Amgen has a market cap or net worth of MXN 3.02 trillion. The enterprise value is 3.94 trillion.

Market Cap	3.02T
Enterprise Value	3.94T

Important Dates

The next estimated earnings date is Monday, August 4, 2025.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	May 16, 2025

Share Statistics

Current Share Class	537.71M
Shares Outstanding	n/a
Shares Change (YoY)	+0.88%
Shares Change (QoQ)	-0.18%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	536.32M

Valuation Ratios

The trailing PE ratio is 24.90 and the forward PE ratio is 14.33.

PE Ratio	24.90
Forward PE	14.33
PS Ratio	4.33
PB Ratio	23.80
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.06, with an EV/FCF ratio of 17.66.

EV / Earnings	32.48
EV / Sales	6.10
EV / EBITDA	13.06
EV / EBIT	20.28
EV / FCF	17.66

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 9.24.

Current Ratio	1.17
Quick Ratio	0.74
Debt / Equity	9.24
Debt / EBITDA	3.60
Debt / FCF	5.26
Interest Coverage	2.88

Financial Efficiency

Return on equity (ROE) is 105.67% and return on invested capital (ROIC) is 9.67%.

Return on Equity (ROE)	105.67%
Return on Assets (ROA)	7.04%
Return on Invested Capital (ROIC)	9.67%
Return on Capital Employed (ROCE)	15.47%
Revenue Per Employee	24.91M
Profits Per Employee	4.33M
Employee Count	28,000
Asset Turnover	0.37
Inventory Turnover	1.37

Taxes

In the past 12 months, Amgen has paid 14.65 billion in taxes.

Income Tax	14.65B
Effective Tax Rate	10.78%

Stock Price Statistics

The stock price has decreased by -0.24% in the last 52 weeks. The beta is 0.48, so Amgen's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	-0.24%
50-Day Moving Average	5,621.37
200-Day Moving Average	5,037.57
Relative Strength Index (RSI)	54.78
Average Volume (20 Days)	1,254

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.61

Income Statement

In the last 12 months, Amgen had revenue of MXN 697.50 billion and earned 121.26 billion in profits. Earnings per share was 223.66.

Revenue	697.50B
Gross Profit	481.74B
Operating Income	209.81B
Pretax Income	135.92B
Net Income	121.26B
EBITDA	321.42B
EBIT	209.81B
Earnings Per Share (EPS)	223.66

Balance Sheet

The company has 180.07 billion in cash and 1.17 trillion in debt, giving a net cash position of -992.74 billion.

Cash & Cash Equivalents	180.07B
Total Debt	1.17T
Net Cash	-992.74B
Net Cash Per Share	n/a
Equity (Book Value)	126.86B
Book Value Per Share	235.94
Working Capital	80.14B

Cash Flow

In the last 12 months, operating cash flow was 249.19 billion and capital expenditures -26.10 billion, giving a free cash flow of 223.09 billion.

Operating Cash Flow	249.19B
Capital Expenditures	-26.10B
Free Cash Flow	223.09B
FCF Per Share	n/a

Margins

Gross margin is 69.07%, with operating and profit margins of 30.08% and 17.39%.

Gross Margin	69.07%
Operating Margin	30.08%
Pretax Margin	19.49%
Profit Margin	17.39%
EBITDA Margin	46.08%
EBIT Margin	30.08%
FCF Margin	31.98%

Dividends & Yields

This stock pays an annual dividend of 182.89, which amounts to a dividend yield of 3.23%.

Dividend Per Share	182.89
Dividend Yield	3.23%
Dividend Growth (YoY)	22.52%
Years of Dividend Growth	1
Payout Ratio	82.64%
Buyback Yield	-0.88%
Shareholder Yield	2.34%
Earnings Yield	4.02%
FCF Yield	7.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amgen has an Altman Z-Score of 1.56 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.56
Piotroski F-Score	6